X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9517) 9517
Book Review (535) 535
Publication (167) 167
Newsletter (130) 130
Magazine Article (65) 65
Newspaper Article (40) 40
Conference Proceeding (29) 29
Dissertation (12) 12
Book Chapter (10) 10
Paper (9) 9
Trade Publication Article (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6555) 6555
humans (5853) 5853
hydrochlorothiazide (4707) 4707
male (4160) 4160
hypertension - drug therapy (3615) 3615
female (3538) 3538
middle aged (3207) 3207
hydrochlorothiazide - therapeutic use (3145) 3145
adult (2355) 2355
aged (2261) 2261
hypertension (2098) 2098
blood pressure - drug effects (1912) 1912
drug therapy, combination (1740) 1740
antihypertensive agents - therapeutic use (1520) 1520
diuretics (1514) 1514
hydrochlorothiazide - administration & dosage (1442) 1442
pharmacology & pharmacy (1306) 1306
hydrochlorothiazide - adverse effects (1251) 1251
hydrochlorothiazide - pharmacology (1225) 1225
double-blind method (1062) 1062
hypertension - physiopathology (1020) 1020
animals (1001) 1001
abridged index medicus (937) 937
drug combinations (873) 873
peripheral vascular disease (855) 855
treatment outcome (743) 743
antihypertensive agents - administration & dosage (717) 717
rats (683) 683
blood pressure (681) 681
diuretics - therapeutic use (673) 673
blood-pressure (655) 655
antihypertensive agents - adverse effects (641) 641
clinical trials as topic (640) 640
time factors (629) 629
old medline (618) 618
medicine, general & internal (574) 574
drug therapy (559) 559
tablets (472) 472
valsartan (462) 462
chemistry, analytical (458) 458
amlodipine (434) 434
cardiac & cardiovascular systems (433) 433
dose-response relationship, drug (428) 428
adolescent (425) 425
hypertension - complications (418) 418
hypertension - blood (408) 408
potassium - blood (406) 406
antihypertensive agents - pharmacology (403) 403
research (389) 389
therapy (387) 387
heart rate - drug effects (377) 377
angiotensin-converting enzyme inhibitors - therapeutic use (370) 370
tetrazoles - therapeutic use (366) 366
risk factors (360) 360
losartan (357) 357
diuretics - pharmacology (333) 333
sodium chloride symporter inhibitors - therapeutic use (327) 327
aged, 80 and over (326) 326
prospective studies (323) 323
double-blind (313) 313
efficacy (301) 301
random allocation (295) 295
combination therapy (294) 294
diuretics - administration & dosage (287) 287
risk (285) 285
dosage and administration (281) 281
analysis (279) 279
diuretics - adverse effects (279) 279
drugs (277) 277
renin - blood (271) 271
follow-up studies (264) 264
urology & nephrology (264) 264
calcium channel blockers - therapeutic use (263) 263
combination (263) 263
amiloride - therapeutic use (254) 254
antihypertensive drugs (252) 252
urine (251) 251
enalapril (248) 248
tetrazoles - administration & dosage (246) 246
captopril (242) 242
potassium (242) 242
management (240) 240
medicine & public health (240) 240
amlodipine - therapeutic use (238) 238
mortality (236) 236
captopril - therapeutic use (235) 235
furosemide - pharmacology (233) 233
angiotensin ii type 1 receptor blockers - therapeutic use (232) 232
prevention (231) 231
telmisartan (228) 228
enalapril - therapeutic use (220) 220
atenolol (218) 218
methods (216) 216
pharmacokinetics (215) 215
performance liquid-chromatography (214) 214
human plasma (212) 212
hydrochlorothiazide - analysis (211) 211
tetrazoles - adverse effects (209) 209
valine - analogs & derivatives (209) 209
drug interactions (208) 208
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8053) 8053
German (441) 441
Italian (285) 285
Russian (282) 282
French (188) 188
Spanish (144) 144
Japanese (64) 64
Chinese (57) 57
Polish (55) 55
Portuguese (55) 55
Czech (38) 38
Hungarian (19) 19
Danish (14) 14
Swedish (14) 14
Norwegian (13) 13
Croatian (12) 12
Romanian (12) 12
Dutch (11) 11
Korean (11) 11
Slovak (6) 6
Hebrew (5) 5
Turkish (5) 5
Bulgarian (3) 3
Finnish (3) 3
Ukrainian (3) 3
Lithuanian (2) 2
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Water Research, ISSN 0043-1354, 01/2011, Volume 45, Issue 3, pp. 1432 - 1442
The occurrence of fifty-five pharmaceuticals, hormones and metabolites in raw waters used for drinking water production and their removal through a drinking... 
Drinking water | Chlorination | Ozonation | GAC | Hormones | Tap water | Pharmaceuticals | PERSONAL CARE PRODUCTS | POLAR DRUG RESIDUES | AQUATIC ENVIRONMENT | WATER RESOURCES | SURFACE-WATER | TANDEM MASS-SPECTROMETRY | ENVIRONMENTAL SCIENCES | ENGINEERING, ENVIRONMENTAL | WASTE-WATER | ENDOCRINE DISRUPTING COMPOUNDS | ORGANIC-COMPOUNDS | MULTI-RESIDUE ANALYSIS | NATIONAL RECONNAISSANCE | Pharmaceutical Preparations - isolation & purification | Sotalol - isolation & purification | Sotalol - chemistry | Phenytoin - isolation & purification | Carbamazepine - chemistry | Phenytoin - chemistry | Water Pollutants, Chemical - isolation & purification | Hormones - analysis | Atenolol - analysis | Carbamazepine - analogs & derivatives | Carbamazepine - analysis | Hormones - isolation & purification | Ozone - chemistry | Hydrochlorothiazide - chemistry | Water Pollutants, Chemical - chemistry | Hormones - chemistry | Water Pollutants, Chemical - analysis | Sotalol - analysis | Atenolol - chemistry | Pharmaceutical Preparations - chemistry | Hydrochlorothiazide - isolation & purification | Phenytoin - analysis | Atenolol - isolation & purification | Hydrochlorothiazide - analysis | Carbamazepine - isolation & purification | Pharmaceutical Preparations - analysis | Water Purification - methods | Water Supply - analysis | Ozonization | Metabolites | Atenolol | Phenytoin | Carbamazepine | Drugs | Filtration | Sand | Raw | Intakes | Index Medicus
Journal Article
Journal of the Renin-Angiotensin-Aldosterone System, ISSN 1470-3203, 12/2015, Volume 16, Issue 4, pp. 1078 - 1084
Objective: We analyzed the efficacy and safety of combination therapy of high-dose losartan (100 mg/day) and hydrochlorothiazide (HCTZ, 12.5 mg/day) compared... 
Angiotensin II type 1 receptor blocker | Blood pressure | Hydrochlorothiazide | Uric acid | Losartan | CARDIOVASCULAR EVENTS | RISK | IDENTIFICATION | angiotensin II type 1 receptor blocker | BLOOD-PRESSURE | SERUM URIC-ACID | TELMISARTAN | TELMISARTAN/HYDROCHLOROTHIAZIDE | INHIBITION | hydrochlorothiazide | DISEASE | LOSARTAN/HYDROCHLOROTHIAZIDE | PERIPHERAL VASCULAR DISEASE | losartan | uric acid | Antihypertensive Agents - pharmacology | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Antihypertensive Agents - administration & dosage | Systole - drug effects | Hypertension - drug therapy | Male | Angiotensin II Type 1 Receptor Blockers - pharmacology | Dose-Response Relationship, Drug | Hypertension - blood | Uric Acid - urine | Heart Rate - drug effects | Hydrochlorothiazide - pharmacology | Female | Blood Pressure - drug effects | Diastole - drug effects | Uric Acid - blood | Drug Therapy, Combination | Hypertension - urine | Hydrochlorothiazide - adverse effects | Losartan - pharmacology | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - therapeutic use | Creatinine - urine | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Losartan - therapeutic use | Losartan - adverse effects | Potassium - blood | Aged | Losartan - administration & dosage | Hydrochlorothiazide - therapeutic use | Index Medicus
Journal Article
Journal of Hypertension, ISSN 0263-6352, 05/2003, Volume 21, Issue 5, pp. 875 - 886
BACKGROUNDThe prognostic benefits of blood pressure lowering treatment in elderly hypertensive patients were established more than a decade ago, but are less... 
Hypertension | Cardiovascular events | Angiotensin II type 1-receptor blockade | Cognitive function | Candesartan | Elderly | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Antihypertensive Agents - administration & dosage | Dementia - diagnosis | Dementia - physiopathology | Hypertension - drug therapy | Male | Dose-Response Relationship, Drug | Benzimidazoles - administration & dosage | Time Factors | Tetrazoles - administration & dosage | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Hypertension - mortality | Benzimidazoles - adverse effects | Hypertension - diagnosis | Benzimidazoles - therapeutic use | Cardiovascular Diseases - diagnosis | Hydrochlorothiazide - adverse effects | Severity of Illness Index | Cardiovascular Diseases - physiopathology | Double-Blind Method | Risk Reduction Behavior | Europe - epidemiology | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Biomarkers - blood | Antihypertensive Agents - therapeutic use | Cognition - drug effects | Antihypertensive Agents - adverse effects | Survival Analysis | Helsinki Declaration | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Hydrochlorothiazide - therapeutic use | Index Medicus | Comparative Study | Cardiovascular Diseases/diagnosis/mortality/physiopathology | Dose-Response Relationship; Drug | Biological Markers/blood | Europe/epidemiology | Aged; 80 and over | Research Support; Non-U.S. Gov't | Antihypertensive Agents/administration & dosage/adverse effects/therapeutic use | Benzimidazoles/administration & dosage/adverse effects/therapeutic use | Hydrochlorothiazide/administration & dosage/adverse effects/therapeutic use | Tetrazoles/administration & dosage/adverse effects/therapeutic use | Dementia/diagnosis/physiopathology | Blood Pressure/drug effects | Cognition/drug effects | Hypertension/diagnosis/drug therapy/mortality
Journal Article
Journal Article
INTERNATIONAL JOURNAL OF PHARMACEUTICS, ISSN 0378-5173, 04/2017, Volume 521, Issue 1-2, pp. 73 - 83
An innovative pediatric oral formulation of hydrochlorothiazide (HCT) (2 mg/mL), endowed with improved bioavailability and sustained release properties and... 
VITRO | Pediatrics | Oral bioavailability | DIURETIC ACTIVITY | NLC | STABILITY | COMPLEXES | CONTROLLED DRUG-DELIVERY | Hydrochlorothiazide | CARRIERS | Cyclodextrin | SLN | PHYSICOCHEMICAL CHARACTERIZATION | BETA-CYCLODEXTRIN | Sustained release | PHARMACOLOGY & PHARMACY | Solid lipid nanoparticles | Hydrochlorothiazide - pharmacokinetics | Nanoparticles - chemistry | Antihypertensive Agents - administration & dosage | Drug Carriers - administration & dosage | Biological Availability | Delayed-Action Preparations - chemistry | Hypertension - drug therapy | Lipids | Male | Drug Carriers - chemistry | Delayed-Action Preparations - administration & dosage | Nanoparticles - metabolism | Cyclodextrins - chemistry | Drug Compounding | Poloxamer - administration & dosage | Poloxamer - chemistry | Drug Evaluation, Preclinical - methods | Administration, Oral | Poloxamer - pharmacokinetics | Cyclodextrins - pharmacokinetics | Hydrochlorothiazide - chemistry | Rats | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - pharmacokinetics | Rats, Sprague-Dawley | Hypertension - metabolism | Antihypertensive Agents - chemistry | Animals | Cyclodextrins - administration & dosage | Pediatrics - methods | Nanoparticles - administration & dosage | Hypertension | Product enhancement | Analysis | Diuretics | Cyclodextrins | Dextrins | Nanoparticles | Surface active agents | Drug therapy, Combination | Children | Health aspects | Index Medicus
Journal Article
Journal Article